Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Schultz

Showing results (221-230 of 310) with videos related to

Pageof 31
Sort By:
JAMA Network Open|July 12, 2021
Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric CancerGeoffrey Y Ku, Yelena Kemel, Steve B Maron, et al.
Neuro-Oncology|March 6, 2015
Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosisE Zeynep Erson-Omay, Ahmet Okay Çağlayan, Nikolaus Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS LymphomaChristian Grommes, Subhiksha Nandakumar, Lauren R Schaff, et al.
Cancer Cell|October 27, 2023
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancersEvelyn Jiagge, Dexter X Jin, Justin Y Newberg, et al.
European Urology|May 13, 2026
IDH1 Mutations Are Associated with Favorable Outcomes in Prostate CancerLuka Cavka, Subhiksha Nandakumar, Qingqing Wu, et al.
European Urology|August 18, 2015
Genomic Characterization of Upper Tract Urothelial CarcinomaJohn P Sfakianos, Eugene K Cha, Gopa Iyer, et al.
Nature Communications|March 2, 2025
Multimodal histopathologic models stratify hormone receptor-positive early breast cancerKevin M Boehm, Omar S M El Nahhas, Antonio Marra, et al.
Gynecologic Oncology|December 2, 2023
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survivalRyan M Kahn, Pier Selenica, Thomas Boerner, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary CancersJohnathan Amsalem, Irina Ostrovnaya, Andrew R Marderstein, et al.
JAMA Surgery|December 23, 2020
A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung AdenocarcinomaGregory D Jones, Whitney S Brandt, Ronglai Shen, et al.
Pageof 31

Showing results (221-230 of 310) with videos related to

Sort By:
Pageof 31
JAMA Network Open|July 12, 2021
Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric CancerGeoffrey Y Ku, Yelena Kemel, Steve B Maron, et al.
Neuro-Oncology|March 6, 2015
Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosisE Zeynep Erson-Omay, Ahmet Okay Çağlayan, Nikolaus Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS LymphomaChristian Grommes, Subhiksha Nandakumar, Lauren R Schaff, et al.
Cancer Cell|October 27, 2023
Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancersEvelyn Jiagge, Dexter X Jin, Justin Y Newberg, et al.
European Urology|May 13, 2026
IDH1 Mutations Are Associated with Favorable Outcomes in Prostate CancerLuka Cavka, Subhiksha Nandakumar, Qingqing Wu, et al.
European Urology|August 18, 2015
Genomic Characterization of Upper Tract Urothelial CarcinomaJohn P Sfakianos, Eugene K Cha, Gopa Iyer, et al.
Nature Communications|March 2, 2025
Multimodal histopathologic models stratify hormone receptor-positive early breast cancerKevin M Boehm, Omar S M El Nahhas, Antonio Marra, et al.
Gynecologic Oncology|December 2, 2023
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survivalRyan M Kahn, Pier Selenica, Thomas Boerner, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary CancersJohnathan Amsalem, Irina Ostrovnaya, Andrew R Marderstein, et al.
JAMA Surgery|December 23, 2020
A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung AdenocarcinomaGregory D Jones, Whitney S Brandt, Ronglai Shen, et al.
Pageof 31